zika

Funding Alert: Contact Congress for Emergency Funding for Zika

Please contact Congress to urge the immediate passage of a bipartisan emergency supplemental bill for Zika.
Take Action

ASM Acts to Counter Zika Virus Outbreak

The emerging threat of Zika virus infection.
Read

ASM Urges Action to Combat Zika Emergency

Current events linked to the Zika virus make aggressive public health actions and funding to combat this emerging infectious disease more crucial than ever.
Read
New Governance Information
VOTE
Become a member today!
JOIN ASM
Submit Abstracts for ABRCMS
SUBMIT
Register for ABRCMS
REGISTER

Antimicrobial Chemotherapy
Division A is concerned with the discovery, mode of action, development and use of antimicrobial agents, and the mechanisms by which infective agents develop resistance to these compounds.

2013 Officers - all terms run from July 1, 2012 to June 30, 2013

Chair
Hanna M. Wexler
UCLA School of Medicine
Los Angeles, CA
hwexler@ucla.edu
310-268-3404

Chair-Elect
Jeffrey D. Alder
Bayer Healthcare Pharmaceuticals Inc.
Montville, NJ
jeff-lisa-alder@hotmail.com

Councilor
Linda A. Miller
GLAXOSMITHKLINE
Collegeville, PA
linda.a.miller@gsk.com
610-917-6280

Division A is part of Divisional Group II - Pathogenesis and Host Response Mechanisms

Divisional Group Representative
Victor DiRita
University of Michigan
Ann Arbor, MI
vdirita@umich.edu


Join DivANet

Website

 

TPL_asm2013_SEARCH

91500